Zai Lab Ltd (ZLAB)
15.84
-0.28
(-1.74%)
USD |
NASDAQ |
Apr 30, 14:47
Zai Lab Enterprise Value: 792.79M for April 29, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 29, 2024 | 792.79M |
| April 26, 2024 | 771.96M |
| April 25, 2024 | 755.09M |
| April 24, 2024 | 747.16M |
| April 23, 2024 | 693.58M |
| April 22, 2024 | 680.69M |
| April 19, 2024 | 589.42M |
| April 18, 2024 | 604.30M |
| April 17, 2024 | 554.69M |
| April 16, 2024 | 624.14M |
| April 15, 2024 | 602.31M |
| April 12, 2024 | 613.23M |
| April 11, 2024 | 682.67M |
| April 10, 2024 | 721.36M |
| April 09, 2024 | 782.87M |
| April 08, 2024 | 730.29M |
| April 05, 2024 | 733.27M |
| April 04, 2024 | 726.32M |
| April 03, 2024 | 770.97M |
| April 02, 2024 | 784.86M |
| April 01, 2024 | 852.32M |
| March 28, 2024 | 782.87M |
| March 27, 2024 | 799.74M |
| March 26, 2024 | 775.93M |
| March 25, 2024 | 805.69M |
| Date | Value |
|---|---|
| March 22, 2024 | 798.75M |
| March 21, 2024 | 904.90M |
| March 20, 2024 | 900.93M |
| March 19, 2024 | 1.006B |
| March 18, 2024 | 987.24M |
| March 15, 2024 | 1.026B |
| March 14, 2024 | 1.133B |
| March 13, 2024 | 1.194B |
| March 12, 2024 | 1.132B |
| March 11, 2024 | 1.179B |
| March 08, 2024 | 1.070B |
| March 07, 2024 | 1.094B |
| March 06, 2024 | 1.158B |
| March 05, 2024 | 1.070B |
| March 04, 2024 | 1.219B |
| March 01, 2024 | 1.287B |
| February 29, 2024 | 1.275B |
| February 28, 2024 | 1.257B |
| February 27, 2024 | 1.425B |
| February 26, 2024 | 1.276B |
| February 23, 2024 | 1.172B |
| February 22, 2024 | 1.186B |
| February 21, 2024 | 1.169B |
| February 20, 2024 | 1.093B |
| February 16, 2024 | 1.231B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-182.09M
Minimum
Aug 12 2019
16.07B
Maximum
Jun 01 2021
3.700B
Average
1.962B
Median
Enterprise Value Benchmarks
| Dr Reddy's Laboratories Ltd | 11.72B |
| Concord Medical Services Holdings Ltd | 998.26M |
| WuXi Biologics (Cayman) Inc | 6.593B |
| I-MAB | -172.81M |
| Gracell Biotechnologies Inc (DELISTED) | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -95.43M |
| Revenue (Quarterly) | 65.83M |
| Total Expenses (Quarterly) | 187.38M |
| EPS Diluted (Quarterly) | -1.00 |
| Gross Profit Margin (Quarterly) | 61.66% |
| Profit Margin (Quarterly) | -145.0% |
| Earnings Yield | -22.10% |
| Normalized Earnings Yield | -21.78 |